<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Afr J Paediatr Surg</journal-id><journal-id journal-id-type="iso-abbrev">Afr J Paediatr Surg</journal-id><journal-id journal-id-type="publisher-id">AJPS</journal-id><journal-title-group><journal-title>African Journal of Paediatric Surgery: AJPS</journal-title></journal-title-group><issn pub-type="ppub">0189-6725</issn><issn pub-type="epub">0974-5998</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26712288</article-id><article-id pub-id-type="pmc">4955476</article-id><article-id pub-id-type="publisher-id">AJPS-12-241</article-id><article-id pub-id-type="doi">10.4103/0189-6725.172553</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Topical treatment of major omphalocoele: <italic>Acacia nilotica</italic> versus povidone-iodine: A randomised controlled study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eltayeb</surname><given-names>Almoutaz A.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Mostafa</surname><given-names>Mahmoud M.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Assiut University Children Hospital, Pediatric Surgery Unit, Assiut University, Asyut, Egypt</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Almoutaz A. Eltayeb, Assiut University, Asyut, Egypt. E-mail: <email xlink:href="almoutazeltayeb@hotmail.com">almoutazeltayeb@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2015</year></pub-date><volume>12</volume><issue>4</issue><fpage>241</fpage><lpage>246</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2015 African Journal of Paediatric Surgery</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Conservative management for major omphalocoele with topical agents as escharotics therapy is well established in practice. Different agents have been used in the past, including mercurochrome and alcohol, proved later to be unsafe. The aim of this study is to evaluate the efficacy and safety of the application of <italic>Acacia nilotica</italic> paste compared to povidone-iodine solution as a primary non-surgical treatment of major omphalocoele.</p></sec><sec id="st2"><title>Patients and Methods:</title><p>A double-blind, randomised study was conducted on 24 cases of major omphalocoele where they were randomly divided into two equal groups; Group A treated with topical application of <italic>A. nilotica</italic> paste and Group B treated with topical application of povidone-iodine solution. Cases with gastroschisis, ruptured major omphalocoele or minor omphalocoele were excluded from the study. The evaluating parameters were size of the fascial defect in cm, period of mechanical ventilation if needed, time required for full oral feeding tolerance, duration of hospital stay and any short- or long-term complications.</p></sec><sec id="st3"><title>Results:</title><p>There was no statistical significant difference between both groups regarding their gestational or post-natal age, weight and the mean umbilical port defect. Patients from Group A tolerated full oral feeding earlier and had shorter total hospital stay duration than those from Group B, but without a statistical significant difference (<italic>P</italic> = 0.347 and 0.242, respectively). The overall mortality rate was 33.3% without a statistical significant difference between both groups (<italic>P</italic> = 0.667).</p></sec><sec id="st4"><title>Conclusions:</title><p>Application of <italic>A. nilotica</italic> is a safe and effective treatment of major omphalocoele as it was associated with rapid full enteral feeding tolerance, short duration of hospital stay and low mortality rate.</p></sec></abstract><kwd-group><title>Key words</title><kwd>Conservative treatment of major omphalocoele</kwd><kwd>topical treatment of major omphalocoele and <italic>Acacia nilotica</italic></kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>BACKGROUND AND PURPOSE</title><p>Closure of major omphalocoeles constitutes a challenge to most surgeons because of the wide fascial defect size, visceroabdominal disproportion and associated congenital anomalies. The lack of sufficient tissues requires the insertion of prosthetic material to bridge the fascial gap with increased risk of infection. Conservative management of major omphalocele with various local dressings is an established practice.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] Different agents have been used for this purpose, including mercurochrome, alcoholic solutions and silver salts, with reported toxicity. Mercurochrome is associated with fatal mercury poisoning, topical alcohol solutions with alcohol toxicity and silver salts have been also used with reported raised silver serum levels.[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>]</p><p><italic>Acacia nilotica</italic> is a spiny tree growing in the Nile Delta, Nile Valley, Sinai and Western desert of Egypt that has been used to treat a variety of conditions, including common cold, bronchitis, diarrhoea, bleeding piles and leucoderma.</p><p>The most evident substances in <italic>A. nilotica</italic> are complex phenolic compounds and polysaccharides (gums). Previous study examined the wound healing, anti-inflammatory and antibacterial activities of extracted and formulated bioactive compounds of <italic>A. nilotica</italic> using different topical bases.[<xref rid="ref11" ref-type="bibr">11</xref>]</p><p>The aim of this study is to evaluate the safety and efficacy of <italic>A. nilotica</italic> paste application as an initial topical treatment of major omphalocoele in comparison to povidone-iodine solution.</p></sec><sec sec-type="methods" id="sec1-2"><title>PATIENTS AND METHODS</title><p>This double-blind, randomised study was conducted at Assiut University Children's Hospital from October 2010 to April 2015 and included 24 cases with major omphalocoele (14 males and 10 females) [<xref ref-type="fig" rid="F1">Figure 1</xref>]. The inclusion criteria were; major omphalocoele where surgical closure was not safe either because of their low birth weight, associated anomalies or large fascial defect with visceroabdominal disproportion. The 24 cases were divided into two equal groups; Group A managed by application of <italic>A. nilotica</italic> paste and Group B managed by application of povidone-iodine 5% solution. Randomisation was done using closed envelope to decide the initial topical treatment option. The antenatal variables included their antenatal diagnosis, mode of delivery, gestational age. The post-natal variables included age at the start of treatment, birth weight size of the defect in cm and the degree of respiratory distress which was evaluated according to Down's score,[<xref rid="ref12" ref-type="bibr">12</xref>] period of mechanical ventilation if needed, time needed for full oral feeding tolerance, total duration of hospital stay and any short-term (during application of either types of dressings) or long-term complications during the follow-up period. Cases with major omphalocoele that could be closed primary based on the clinical assessment were excluded from the study and also cases with gastroschisis, ruptured major omphalocoele or minor omphalocoele were excluded. A written informed consent was taken from all the parents or guardians for participation in this study with either type of topical dressings. Approval of the Regional Ethical Committee of Faculty of Medicine was obtained to conduct this study.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Major omphalocoele containing liver</p></caption><graphic xlink:href="AJPS-12-241-g001"/></fig><sec id="sec2-1"><title>Preparation and application technique</title><p>For patients from Group A, the commercially available <italic>A. nilotica</italic> powder was mixed with a ratio of 1:1 with gentian violet solution as a solvent to obtain the <italic>A. nilotica</italic> paste. Application of this paste to the intact sac twice daily is done, and then the sac was left exposed without dressing [<xref ref-type="fig" rid="F2">Figure 2</xref>]. For patients from Group B, the povidone-iodine (5% solution) was applied directly to the sac with sterile dressing with the same frequency of <italic>A. nilotica</italic> paste. Routine thyroid function tests were performed for all the cases on admission, repeated on 2 weeks basis after the start of treatment with povidone-iodine and every follow-up visit thereafter. The patients were discharged from the hospital when they are taking full oral feeding and in a stable, general condition. The dressings to all the patients were continued after discharge, until the sac is shed off and skin has covered the defect [<xref ref-type="fig" rid="F3">Figure 3</xref>].</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Male baby after the application of <italic>Acacia nilotica</italic> and gentian violet</p></caption><graphic xlink:href="AJPS-12-241-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Female baby after 7 months of the application of <italic>Acacia nilotica</italic> with a ventral hernia and scar at the umbilical port</p></caption><graphic xlink:href="AJPS-12-241-g003"/></fig></sec><sec id="sec2-2"><title>Statistical analysis</title><p>The data were analysed using SPSS<sup>&#x000ae;</sup> (version 16; SPSS Chicago, Illinois, USA) and descriptive statistics (i.e., mean, standard deviation and percentage) was calculated. &#x02018;Mann-Whitney Test&#x02019; and Fisher's exact test were used to compare the means between the groups. The difference was considered as significant if <italic>P</italic> &#x02264; 0.05.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>There was no statistical significant difference between both groups regarding their sex, gestational age and post-natal age. The mode of delivery and associated anomalies in the 24 cases are listed in Tables <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>. Antenatal diagnosis was made only in 8 cases (3 from Group A and 5 from Group B). The mean birth weight for patients within Group A was 2.37 &#x000b1; 0.55 kg (range: 1.5-3.1 kg) and for patients within Group B was 2.33 &#x000b1; 0.65 kg (range: 1.4-3.2 kg) (<italic>P</italic> = 0.713). Furthermore, the mean fascial defect size in the patients from Group A was 11.75 &#x000b1; 3.19 cm (range: 7-16 cm) where it was 10.66 &#x000b1; 3.55 cm in Group B (range: 6-18 cm) (<italic>P</italic> = 0.410). Patients from both groups had respiratory distress score ranged from 0 to 6. The mean value for respiratory distress score in Group A was 1.97 &#x000b1; 2.19 and 1.75 &#x000b1; 1.65 in Group B (<italic>P</italic> = 0.977). Two cases from Group B developed local infection; one of them progressed to ruptured sac where silo bag was fixed. Both died later because of sepsis and disseminated intravascular coagulopathy. Although patients from Group A reached to full oral feeding tolerance earlier than those from Group B, (7.25 &#x000b1; 5.04 days &#x02260; 9.83 &#x000b1; 8.99 days) this difference did not reach statistical significance (<italic>P</italic> = 0.347). The mean total duration of hospital stay among patients from Group A was shorter than those from Group B (15.58 &#x000b1; 8.10 days &#x02260; 18.66 &#x000b1; 12.74 days), but the difference did not reach statistical significant difference (<italic>P</italic> = 0.242).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>shows mode of delivery, birth weight, defect size, associated congenital anomalies, complications and outcome in patients treated by local application of Acacia Nilotica paste (group A).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">No.</th><th align="center" rowspan="1" colspan="1">Mode of delivery</th><th align="center" rowspan="1" colspan="1">Weight</th><th align="center" rowspan="1" colspan="1">Defect size</th><th align="left" rowspan="1" colspan="1">Associated congenital anomalies</th><th align="center" rowspan="1" colspan="1">Complications</th><th align="left" rowspan="1" colspan="1">Outcome</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">2.447 gm</td><td align="center" rowspan="1" colspan="1">14 cm</td><td align="left" rowspan="1" colspan="1">Hypospadias</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">2.500 gm</td><td align="center" rowspan="1" colspan="1">7 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">1.610 gm</td><td align="center" rowspan="1" colspan="1">16 cm</td><td align="left" rowspan="1" colspan="1">VSD, PDA</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">died</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">2.580 gm</td><td align="center" rowspan="1" colspan="1">11 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">2.960 gm</td><td align="center" rowspan="1" colspan="1">9 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">2.434 gm</td><td align="center" rowspan="1" colspan="1">12 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">1.900 gm</td><td align="center" rowspan="1" colspan="1">14 cm</td><td align="left" rowspan="1" colspan="1">Lung hypoplasia</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">died</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">1.500 gm</td><td align="center" rowspan="1" colspan="1">15 cm</td><td align="left" rowspan="1" colspan="1">VSD, pulmonary art. Stenosis</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">died</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">2.800 gm</td><td align="center" rowspan="1" colspan="1">8 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">3.104 gm</td><td align="center" rowspan="1" colspan="1">10 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">2.900 gm</td><td align="center" rowspan="1" colspan="1">9 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">1.721 gm</td><td align="center" rowspan="1" colspan="1">16 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr></tbody></table><table-wrap-foot><fn><p>CS: caesarean section, NVD: normal vaginal delivery, PDA: patent ductus arteriosus, VSD: ventricular septal defect.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>shows mode of delivery, birth weight, defect size, associated congenital anomalies, complications and outcome in patients treated by local application of povidone iodine (group B).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">No.</th><th align="center" rowspan="1" colspan="1">Mode of delivery</th><th align="center" rowspan="1" colspan="1">Weight</th><th align="center" rowspan="1" colspan="1">Defect size</th><th align="left" rowspan="1" colspan="1">Associated congenital anomalies</th><th align="center" rowspan="1" colspan="1">Complications</th><th align="left" rowspan="1" colspan="1">Outcome</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">2.300 gm</td><td align="center" rowspan="1" colspan="1">8 cm</td><td align="left" rowspan="1" colspan="1">ASD</td><td align="center" rowspan="1" colspan="1">Sepsis</td><td align="left" rowspan="1" colspan="1">died</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">1.850 gm</td><td align="center" rowspan="1" colspan="1">18 cm</td><td align="left" rowspan="1" colspan="1">Lung hypoplasia</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">died</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">1.400 gm</td><td align="center" rowspan="1" colspan="1">9 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">died</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">2.410 gm</td><td align="center" rowspan="1" colspan="1">10 cm</td><td align="left" rowspan="1" colspan="1">UDT</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">2.785 gm</td><td align="center" rowspan="1" colspan="1">8 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">1.670 gm</td><td align="center" rowspan="1" colspan="1">11 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">died</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">2.350 gm</td><td align="center" rowspan="1" colspan="1">6 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">1.780 gm</td><td align="center" rowspan="1" colspan="1">14 cm</td><td align="left" rowspan="1" colspan="1">VSD</td><td align="center" rowspan="1" colspan="1">Sepsis and rupture</td><td align="left" rowspan="1" colspan="1">died</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">2.910 gm</td><td align="center" rowspan="1" colspan="1">10 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">NVD</td><td align="center" rowspan="1" colspan="1">3.120 gm</td><td align="center" rowspan="1" colspan="1">15 cm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">3.240 gm</td><td align="center" rowspan="1" colspan="1">12 cm</td><td align="left" rowspan="1" colspan="1">Limb anomaly</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">2.750 gm</td><td align="center" rowspan="1" colspan="1">7 cm</td><td align="left" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">survived</td></tr></tbody></table><table-wrap-foot><fn><p>CS: caesarean section, NVD: normal vaginal delivery, UDT: undescended testes, ASD: atrial septal defect, VSD: ventricular septal defect</p></fn></table-wrap-foot></table-wrap><p>After application of the <italic>A. nilotica</italic> paste, the sac becomes firm and very tough in structure without any signs of infection or other local or systemic complications. The sac gradually came off and skin covered the defect over a mean period of 7.83 &#x000b1; 4.82 weeks in group A, where it came off over a mean period of 7.42 &#x000b1; 6.59 weeks in Group B (<italic>P</italic> = 0.861). No changes were recorded for the thyroid function tests among the patients from Group B either during treatment or follow-up visits.</p><p>The overall mortality was 8 cases out of 24; 5 from Group B and 3 from Group A (<italic>P</italic> = 0.667). All those 8 cases needed mechanical ventilation for a period ranged from 2 to 6 days because of respiratory distress either due to prematurity, lung hypoplasia or pneumonia and died because of respiratory failure and sepsis [Tables <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>].</p><p>The mean follow-up period was 15.5 &#x000b1;3.5 months during this period, the 16 survived babies were gaining weight and were using elastic bandages regularly, to gradually increase the abdominal domain; where 7 cases were subjected to safe fascial closure in one setting based on clinical assessment without the insertion of prosthetic material or postoperative ventilation.</p></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>In the recent years, an increase in the incidence of omphalocoele has been reported in the different parts of the world with slight male predominance reported in some series.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref13" ref-type="bibr">13</xref>] This goes with this study where 58% were males.</p><p>Most abdominal wall defects are now diagnosed prenatally, which helps to choose the appropriate location, mode and timing of delivery and facilitate post-natal evaluation and management.[<xref rid="ref14" ref-type="bibr">14</xref>] We had 33.3% of cases in this series diagnosed prenatally. This may be related to the lack of facilities and specialised medical service in the remote health care centres.</p><p>Although caesarean delivery is still commonly performed for large omphalocoeles with liver herniation, no difference was found in the survival or complication rates between the infants delivered by normal vaginal delivery or by caesarean section.[<xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref>] In this study, we had 64% of babies delivered by normal vaginal delivery with no difference in the survival or complication rates between them and those delivered by caesarean section.</p><p>Primary fascial closure of large omphalocoeles could raise the intra-abdominal pressure resulting in pulmonary and renal failure. Silastic silo was used to allow gradual return of the abdominal viscera, which may be associated with morbidity, including wound infection and dehiscence, recurrent ventral hernia, bowel obstruction and pulmonary damage, caused by prolonged mechanical ventilation. Furthermore, shock and renal failure from compression and kinking of the inferior vena cava and possibly from abdominal compartment syndrome besides its need to general anaesthesia are all known associated risks.[<xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref>] Other options for the closure of large omphalocoeles, including the mobilisation of large skin flaps and skin closure only, placement of prosthetic material and in folding of the amniotic sac without resection, have been tried.[<xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref20" ref-type="bibr">20</xref>] All these methods have some advantages and are indicated in certain situations; however, none of these methods allow closure of the abdominal wall defect without the use of prosthetic material or multiple operations.</p><p>Conservative management of giant omphalocoeles was first described in 1899 by Ahlfeld using alcohol as a topical agent.[<xref rid="ref21" ref-type="bibr">21</xref>] In the 1950s and 1960s, escharotics therapy was popularised by Grob.[<xref rid="ref22" ref-type="bibr">22</xref>] This therapy allowed the sac to desiccate, contract and eventually the defect was epithelialised, which left a ventral hernia that could be repaired later in life. This approach has the general advantage of completely avoiding the major abdominal surgery in the neonatal period with the risks of tight abdominal closure with its morbidity and mortality as well as the complications of silon placement. This conservative escharotic therapy is also used for the high-risk infants with large omphalocoeles and prematurity, respiratory insufficiency, congenital heart disease or chromosomal abnormalities who cannot tolerate the surgery with low complication rates.[<xref rid="ref23" ref-type="bibr">23</xref>] Although different agents have been used in the past, they proved to be potentially toxic and should be avoided.[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] The use of topical silver sulphadiazine (SSD) cream to provide initial sac coverage was first reported in 1987 by Hatch and Baxter.[<xref rid="ref24" ref-type="bibr">24</xref>] Lee <italic>et al</italic>.,[<xref rid="ref25" ref-type="bibr">25</xref>] and Ein and Langer,[<xref rid="ref4" ref-type="bibr">4</xref>] reported in their series the safety and efficacy of SSD as it provides a moist wound healing environment that promotes epithelialisation and simultaneously minimises the risk of infection. Although the reported risks of silver toxicity, including seizures, peripheral neuropathy, ocular pathology, nephrotic syndrome, raised liver enzymes and leucopenia, are well documented in the literature, the duration of exposure and dosage leading to this toxicity are not well established as there are no reports of the long-term outcome of elevated silver serum levels in neonates yet.[<xref rid="ref10" ref-type="bibr">10</xref>] Even topical application of povidone-iodine has been associated with a known risk of hypothyroidism.[<xref rid="ref9" ref-type="bibr">9</xref>] In this study, we did not encounter any case of hypothyroidism among Group B either during treatment or follow-up period.</p><p>The use of plants for healing purposes predates human history and forms the origin of much modern medicine. Many conventional drugs originate from plant sources; including acetylsalicylic acid from willow bark,[<xref rid="ref26" ref-type="bibr">26</xref>] digoxin from foxglove[<xref rid="ref27" ref-type="bibr">27</xref>] and morphine from the opium poppy.[<xref rid="ref28" ref-type="bibr">28</xref>]</p><p><italic>A. nilotica</italic> is one of about 135 thorny African Acacia species.[<xref rid="ref29" ref-type="bibr">29</xref>] The presumed mechanism of action after the application of <italic>A. nilotica</italic> paste that it induces coagulation of the protein contents of the sac (Wharton jelly), preventing protein fermentation, changing the sac to a very tough structure, which prevents fluid losses from the sac and acts as a barrier against invasion by microorganisms.[<xref rid="ref11" ref-type="bibr">11</xref>]</p><p>Some authors reported that conservative approach in major omphalocoele was associated with prolonged time for full oral feeding tolerance and requires a long duration of hospital stay.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref23" ref-type="bibr">23</xref>] In this series, patients treated with either topical application of <italic>A. nilotica</italic> paste or povidone-iodine solution have relatively rapid tolerance to full oral feeding and short total hospital duration compared to those reports.</p><p>The outcome for a neonate with exomphalos is dependent on different variables such as the severity of associated anomalies and degree of prematurity.[<xref rid="ref3" ref-type="bibr">3</xref>] In the previous series,[<xref rid="ref30" ref-type="bibr">30</xref><xref rid="ref31" ref-type="bibr">31</xref><xref rid="ref32" ref-type="bibr">32</xref>] the incidence of congenital anomalies ranged from 45% to 77%. This is nearly similar to our study where the associated anomalies were encountered in 43.4% of patients. There was no statistical significant difference between both groups regarding the associated congenital anomalies or other risk factors in this study, which were the low birth weight and umbilical port size with visceraabdominal disproportion. In spite of the presence of all these risk factors, the patients from Group A had low mortality rate (25%) compared to the patients from Group B (41.7%) <italic>P</italic> = 0.667. Vachharajani <italic>et al</italic>.,[<xref rid="ref33" ref-type="bibr">33</xref>] reported an overall mortality rate of 33% in all the cases with major omphalocoele treated by a different method; primary surgical closure and silo placement. Ein and Langer,[<xref rid="ref4" ref-type="bibr">4</xref>] reported nearly the same mortality rate (30%) in cases with major omphalocoele treated conservatively by SSD. Both attributed their mortality to prematurity and pulmonary hypoplasia. In this study, the overall mortality rate was 33.3% and was also related to prematurity, lung hypoplasia and sepsis.</p><p>External compression with bandages have been used as a treatment option either early during neonatal period[<xref rid="ref34" ref-type="bibr">34</xref><xref rid="ref35" ref-type="bibr">35</xref>] or delayed during infancy.[<xref rid="ref20" ref-type="bibr">20</xref>] We choose to use the elastic external compression in a stabilised infant, where seven patients had single safe fascial closure of their ventral hernias without prosthetic materials insertion or postoperative mechanical ventilation.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Both <italic>A. nilotica</italic> paste and povidone-iodine solution are safe and effective initial topical treatments of major omphalocoeles. Application of <italic>A. nilotica</italic> paste was associated with rapid full enteral feeding tolerance, short duration of hospital stay and low mortality rate. Furthermore, it is cheap, natural, easy to apply and non-toxic preparation.</p><sec id="sec2-3"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-4"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Minkes</surname><given-names>RK</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Oldham</surname><given-names>KT</given-names></name><name><surname>Colombani</surname><given-names>PM</given-names></name><name><surname>Foglia</surname><given-names>RP</given-names></name><name><surname>Skinner</surname><given-names>MA</given-names></name></person-group><article-title>Abdominal wall defects</article-title><source>Principles and Practice of Pediatric Surgery</source><year>2005</year><publisher-loc>Philadelphia (PA)</publisher-loc><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><fpage>1103</fpage><lpage>19</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudrun</surname><given-names>A</given-names></name><name><surname>Jacob</surname><given-names>CL</given-names></name></person-group><article-title>Abdominal wall defects</article-title><source>J Curr Pediatr</source><year>2006</year><volume>16</volume><fpage>192</fpage><lpage>8</lpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rijhwani</surname><given-names>A</given-names></name><name><surname>Davenport</surname><given-names>M</given-names></name><name><surname>Dawrant</surname><given-names>M</given-names></name><name><surname>Dimitriou</surname><given-names>G</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Greenough</surname><given-names>A</given-names></name><etal/></person-group><article-title>Definitive surgical management of antenatally diagnosed exomphalos</article-title><source>J Pediatr Surg</source><year>2005</year><volume>40</volume><fpage>516</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15793728</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ein</surname><given-names>SH</given-names></name><name><surname>Langer</surname><given-names>JC</given-names></name></person-group><article-title>Delayed management of giant omphalocele using silver sulfadiazine cream: An 18-year experience</article-title><source>J Pediatr Surg</source><year>2012</year><volume>47</volume><fpage>494</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">22424344</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luijendijk</surname><given-names>RW</given-names></name><name><surname>Hop</surname><given-names>WC</given-names></name><name><surname>van den Tol</surname><given-names>MP</given-names></name><name><surname>de Lange</surname><given-names>DC</given-names></name><name><surname>Braaksma</surname><given-names>MM</given-names></name><name><surname>IJzermans</surname><given-names>JN</given-names></name><etal/></person-group><article-title>A comparison of suture repair with mesh repair for incisional hernia</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><fpage>392</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10933738</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakhlu</surname><given-names>A</given-names></name><name><surname>Wakhlu</surname><given-names>AK</given-names></name></person-group><article-title>The management of exomphalos</article-title><source>J Pediatr Surg</source><year>2000</year><volume>35</volume><fpage>73</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10646778</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>ME</given-names></name><name><surname>Horowitz</surname><given-names>BZ</given-names></name></person-group><article-title>Iatrogenic neonatal mercury poisoning from Mercurochrome treatment of a large omphalocele</article-title><source>Clin Pediatr (Phila)</source><year>1999</year><volume>38</volume><fpage>111</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">10047945</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gough</surname><given-names>DC</given-names></name><name><surname>Auldist</surname><given-names>AW</given-names></name></person-group><article-title>Giant exomphalos &#x02014; Conservative or operative treatment?</article-title><source>Arch Dis Child</source><year>1979</year><volume>54</volume><fpage>441</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">89835</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Festen</surname><given-names>C</given-names></name><name><surname>Severijnen</surname><given-names>RS</given-names></name><name><surname>vd Staak</surname><given-names>FH</given-names></name></person-group><article-title>Nonsurgical (conservative) treatment of giant omphalocele. A report of 10 cases</article-title><source>Clin Pediatr (Phila)</source><year>1987</year><volume>26</volume><fpage>35</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3791837</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>N</given-names></name><name><surname>Kolimarala</surname><given-names>V</given-names></name><name><surname>Lander</surname><given-names>A</given-names></name></person-group><article-title>Conservative management of exomphalos major with silver dressings: Are they safe?</article-title><source>J Pediatr Surg</source><year>2010</year><volume>45</volume><fpage>2438</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21129562</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>IK</given-names></name><name><surname>Fetouh</surname><given-names>MI</given-names></name><name><surname>Mostafa</surname><given-names>MM</given-names></name><name><surname>Ibrahim</surname><given-names>I</given-names></name></person-group><article-title>The Use of Parts from Medicinal Plants in Different Pharmaceutical Dosage form in Treatment of Some Surgical Cases</article-title><year>2009</year><publisher-loc>Assiut</publisher-loc><publisher-name>Master Degree of Pharmaceutical Sciences, Al-Azhar University</publisher-name></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>DW</given-names></name><name><surname>Downes</surname><given-names>JJ</given-names></name><name><surname>Lecks</surname><given-names>HI</given-names></name></person-group><article-title>A clinical scoring system for the diagnosis of respiratory failure. Preliminary report on childhood status asthmaticus</article-title><source>Am J Dis Child</source><year>1972</year><volume>123</volume><fpage>227</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">5026202</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cooney</surname><given-names>DR</given-names></name></person-group><person-group person-group-type="editor"><name><surname>O&#x02019;Neill</surname><given-names>JA</given-names><suffix>Jr</suffix></name><name><surname>Rowe</surname><given-names>MI</given-names></name><name><surname>Grosfeld</surname><given-names>JL</given-names></name><name><surname>Fonkalsrud</surname><given-names>EW</given-names></name><name><surname>Coran</surname><given-names>AG</given-names></name></person-group><article-title>Defects of the abdominal wall</article-title><source>Pediatric Surgery</source><year>1998</year><edition>5th ed</edition><publisher-loc>St. Louis</publisher-loc><publisher-name>Mosby</publisher-name><fpage>1045</fpage><lpage>69</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crombleholme</surname><given-names>TM</given-names></name><name><surname>D&#x02019;Alton</surname><given-names>M</given-names></name><name><surname>Cendron</surname><given-names>M</given-names></name><name><surname>Alman</surname><given-names>B</given-names></name><name><surname>Goldberg</surname><given-names>MD</given-names></name><name><surname>Klauber</surname><given-names>GT</given-names></name><etal/></person-group><article-title>Prenatal diagnosis and the pediatric surgeon: The impact of prenatal consultation on perinatal management</article-title><source>J Pediatr Surg</source><year>1996</year><volume>31</volume><fpage>156</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">8632271</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adra</surname><given-names>AM</given-names></name><name><surname>Landy</surname><given-names>HJ</given-names></name><name><surname>Nahmias</surname><given-names>J</given-names></name><name><surname>G&#x000f3;mez-Mar&#x000ed;n</surname><given-names>O</given-names></name></person-group><article-title>The fetus with gastroschisis: Impact of route of delivery and prenatal ultrasonography</article-title><source>Am J Obstet Gynecol</source><year>1996</year><volume>174</volume><fpage>540</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8623781</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>RA</given-names></name><name><surname>Balu</surname><given-names>R</given-names></name><name><surname>Kuller</surname><given-names>JA</given-names></name><name><surname>McMahon</surname><given-names>MJ</given-names></name></person-group><article-title>Gastroschisis: The effect of labor and ruptured membranes on neonatal outcome</article-title><source>Am J Obstet Gynecol</source><year>2003</year><volume>189</volume><fpage>1672</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14710097</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>DK</given-names></name><name><surname>Mutich</surname><given-names>R</given-names></name><name><surname>Motoyama</surname><given-names>EK</given-names></name></person-group><article-title>Pulmonary dysfunction after primary closure of an abdominal wall defect and its improvement with bronchodilators</article-title><source>Pediatr Pulmonol</source><year>1992</year><volume>12</volume><fpage>174</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">1386420</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>AS</given-names></name><name><surname>Corbally</surname><given-names>MT</given-names></name><name><surname>Fitzgerald</surname><given-names>RJ</given-names></name></person-group><article-title>Evaluation of conservative therapy for exomphalos</article-title><source>Surg Gynecol Obstet</source><year>1991</year><volume>172</volume><fpage>394</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1709307</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>RE</given-names></name></person-group><article-title>A new method for surgical treatment of large omphaloceles</article-title><source>Surgery</source><year>1998</year><volume>24</volume><fpage>277</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">18872858</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MF</given-names></name><name><surname>Wright</surname><given-names>L</given-names></name></person-group><article-title>Delayed external compression reduction of an omphalocele (DECRO): An alternative method of treatment for moderate and large omphaloceles</article-title><source>J Pediatr Surg</source><year>1998</year><volume>33</volume><fpage>1113</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9694105</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>DA</given-names></name><name><surname>Truong</surname><given-names>QD</given-names></name><name><surname>Nguyen</surname><given-names>MT</given-names></name></person-group><article-title>Topical application of povidone-iodine solution (Betadine) in the management of giant omphaloceles</article-title><source>Dermatology</source><year>2006</year><volume>212</volume><issue>Suppl 1</issue><fpage>88</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">16490981</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grob</surname><given-names>M</given-names></name></person-group><article-title>Conservative treatment of exomphalos</article-title><source>Arch Dis Child</source><year>1963</year><volume>38</volume><fpage>148</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">13950613</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuchtern</surname><given-names>JG</given-names></name><name><surname>Baxter</surname><given-names>R</given-names></name><name><surname>Hatch</surname><given-names>EI</given-names><suffix>Jr</suffix></name></person-group><article-title>Nonoperative initial management versus silon chimney for treatment of giant omphalocele</article-title><source>J Pediatr Surg</source><year>1995</year><volume>30</volume><fpage>771</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7666304</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatch</surname><given-names>EI</given-names><suffix>Jr</suffix></name><name><surname>Baxter</surname><given-names>R</given-names></name></person-group><article-title>Surgical options in the management of large omphaloceles</article-title><source>Am J Surg</source><year>1987</year><volume>153</volume><fpage>449</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">3578667</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SL</given-names></name><name><surname>Beyer</surname><given-names>TD</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Waldhausen</surname><given-names>JH</given-names></name><name><surname>Healey</surname><given-names>PJ</given-names></name><name><surname>Sawin</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Initial nonoperative management and delayed closure for treatment of giant omphaloceles</article-title><source>J Pediatr Surg</source><year>2006</year><volume>41</volume><fpage>1846</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17101356</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bisset</surname><given-names>NG</given-names></name></person-group><article-title>Herbal Drugs and Phytopharmaceuticals</article-title><year>2004</year><publisher-loc>Stuttgart, Germany</publisher-loc><publisher-name>Medpharm Scientific Publishers</publisher-name><fpage>534</fpage><lpage>6</lpage></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Qura&#x02019;n</surname><given-names>S</given-names></name></person-group><article-title>Ethnopharmacological survey of wild medicinal plants in Showbak, Jordan</article-title><source>J Ethnopharmacol</source><year>2009</year><volume>123</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">19429338</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>S</given-names></name><name><surname>Suemori</surname><given-names>K</given-names></name><name><surname>Moriwaki</surname><given-names>J</given-names></name><name><surname>Taura</surname><given-names>F</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Aso</surname><given-names>M</given-names></name><etal/></person-group><article-title>Morphine metabolism in the opium poppy and its possible physiological function. Biochemical characterization of the morphine metabolite, bismorphine</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>38179</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">11498543</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Brenan</surname><given-names>JP</given-names></name></person-group><article-title>Manual on taxonomy of Acacia species: Present taxonomy of four species of <italic>Acacia</italic> (<italic>A. albida</italic>, <italic>A. senegal</italic>, <italic>A. tortilis and A. nilotica</italic>)</article-title><year>1983</year><publisher-loc>Rome, Italy</publisher-loc><publisher-name>FAO</publisher-name><fpage>47</fpage><lpage>54</lpage></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>PA</given-names></name><name><surname>Bhattacharjee</surname><given-names>A</given-names></name><name><surname>Gould</surname><given-names>S</given-names></name><name><surname>Manning</surname><given-names>N</given-names></name><name><surname>Chamberlain</surname><given-names>P</given-names></name></person-group><article-title>Outcome of prenatally diagnosed anterior abdominal wall defects</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>1998</year><volume>78</volume><fpage>F209</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">9713034</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yazbeck</surname><given-names>S</given-names></name><name><surname>Ndoye</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>AH</given-names></name></person-group><article-title>Omphalocele: A 25-year experience</article-title><source>J Pediatr Surg</source><year>1986</year><volume>21</volume><fpage>761</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">3772699</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>JC</given-names></name><name><surname>Fonkalsrud</surname><given-names>EW</given-names></name></person-group><article-title>Improved survival of infants with omphalocele</article-title><source>Am J Surg</source><year>1997</year><volume>173</volume><fpage>284</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9136781</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vachharajani</surname><given-names>AJ</given-names></name><name><surname>Rao</surname><given-names>R</given-names></name><name><surname>Keswani</surname><given-names>S</given-names></name><name><surname>Mathur</surname><given-names>AM</given-names></name></person-group><article-title>Outcomes of exomphalos: An institutional experience</article-title><source>Pediatr Surg Int</source><year>2009</year><volume>25</volume><fpage>139</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">19066916</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>B</given-names></name><name><surname>Cooper</surname><given-names>A</given-names></name><name><surname>Gandhi</surname><given-names>R</given-names></name><name><surname>Niemirska</surname><given-names>M</given-names></name></person-group><article-title>External silo reduction of the unruptured giant omphalocele</article-title><source>J Pediatr Surg</source><year>1987</year><volume>22</volume><fpage>75</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3819999</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLuca</surname><given-names>FG</given-names></name><name><surname>Gilchrist</surname><given-names>BF</given-names></name><name><surname>Paquette</surname><given-names>E</given-names></name><name><surname>Wesselhoeft</surname><given-names>CW</given-names></name><name><surname>Luks</surname><given-names>FI</given-names></name></person-group><article-title>External compression as initial management of giant omphaloceles</article-title><source>J Pediatr Surg</source><year>1996</year><volume>31</volume><fpage>965</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8811569</pub-id></element-citation></ref></ref-list></back></article>